1. Role of β2-Adrenoreceptors in Adrenergic Anti-Inflammatory Mechanism in Sepsis
- Author
-
V. V. Maslyakov, M. S. Gromov, and P. F. Zabrodskii
- Subjects
Male ,0301 basic medicine ,Agonist ,Adrenergic receptor ,medicine.drug_class ,Interleukin-1beta ,Anti-Inflammatory Agents ,Hexoprenaline ,Adrenergic ,Pharmacology ,General Biochemistry, Genetics and Molecular Biology ,Anti-inflammatory ,Proinflammatory cytokine ,Propanolamines ,Sepsis ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Adrenergic beta-2 Receptor Antagonists ,Animals, Outbred Strains ,Escherichia coli ,medicine ,Animals ,Adrenergic beta-2 Receptor Agonists ,Escherichia coli Infections ,Interleukin-6 ,Tumor Necrosis Factor-alpha ,business.industry ,Antagonist ,General Medicine ,medicine.disease ,Treatment Outcome ,030104 developmental biology ,Female ,Tumor necrosis factor alpha ,Receptors, Adrenergic, beta-2 ,business ,030217 neurology & neurosurgery - Abstract
Experiments on random-bred albino mice showed that of β2-adrenoreceptor agonist hexaprenaline sulfate significantly reduced mortality of mice from experimental sepsis (intraperitoneal administration of E. coli) in 4 and 24 h after modeling by reducing blood levels of proinflammatory cytokines TNFα, IL-1β, and IL-6. The antagonist of β2AR ICI-118,551 eliminated this effect.
- Published
- 2017
- Full Text
- View/download PDF